Validation Data on More Than 100 Patients published in Journal of Molecular Diagnostics CHICAGO, April 25, 2025 /PRNewswire/ -- Belay Diagnostics, a CLIA/CAP accredited laboratory focused on the ...
CNSide Diagnostics, LLC, a wholly-owned subsidiary of Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), announced today a new payer coverage agreement with Blue Shield of California, ...
Belay Diagnostics peer-reviewed study shows variant allele frequency measured from CSF may support diagnosis and monitoring in leptomeningeal disease CHICAGO, April 14, 2026 /PRNewswire/ -- ...
For decades, diagnosis of brain cancer has been medicine’s most difficult and hazardous challenge. Simple imaging such as MRI scans may reveal a suspicious-looking lesion, but the only sure way to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results